Adverse Drug Reaction
Allergan confirms Botox not involved in death of woman following treatment
Published in Medical Devices and Surgical Technology Week, April 18th, 2006
"This unfortunate incident makes clear how important it is for consumers to seek out licensed, trained and qualified healthcare professionals when considering treatment with Botox and to verify that they are receiving authentic Botox and not an unlicensed botulinum toxin or alternative substance," said Douglas S. Ingram, Allergan's executive VP, general counsel and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Cardiology
In atrial fibrillation, transesophageal echocardiography-guided cardioversion is effective alternative - Head & Neck Cancer
Surgical outcomes for tongue and soft palate squamous cell cancer compared - Hematology
In pediatric cardiac surgery, blood transfusions may be reduced with use of aprotinin - Obesity Therapy
Biliopancreatic diversion led to noticeable reduction in weight and fat gains in rats - Orthopedics
Hip surgery outcomes impacted by age and weight of patients - Adverse Drug Reaction
Cancer treatment regimen combining gefitinib, capecitabine, and radiation produced toxicity - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
